UT Health Sciences and UW–Madison Researchers Partner to Advance Potential Alphavirus Treatment
|Researchers at the University of Tennessee Health Sciences are part of a team working to move a promising antiviral drug one step closer to being tested in humans. The team has received funding from the National Institute of Allergy and Infectious Diseases to conduct studies needed to prepare the drug candidate called BDGR-354, also known… Read More



